Search for a trial | Research with human participants

1 results

A phase II study of sorafenib and metformin in patients with locally advanced and/or metastatic non-smal cell lung cancer (NSCLC) with a K-Ras mutation

Approved WMOCompleted

To assess the efficacy of combined treatment with sorafenib and metformin.